(Q52845037)

8 May 2018

title

A functional XPNPEP2 promoter haplotype leads to reduced plasma aminopeptidase P and increased risk of ACE inhibitor-induced angioedema. (English)

1 reference

8 May 2018

author

Gillian I. Rice

3

1 reference

8 May 2018

Nigel Mark Hooper

8

1 reference

8 May 2018

Guy A. Rouleau

5

object named as

Guy A Rouleau

1 reference

8 May 2018

Amy L Cilia La Corte

1

1 reference

8 May 2018

Angela M Carter

2

1 reference

8 May 2018

Qing Ling Duan

4

1 reference

8 May 2018

Albert Adam

6

1 reference

8 May 2018

Peter J Grant

7

1 reference

8 May 2018

publication date

12 September 2011

1 reference

8 May 2018

published in

Human Mutation

1 reference

8 May 2018

volume

32

1 reference

8 May 2018

issue

11

1 reference

8 May 2018

page(s)

1326-1331

1 reference

8 May 2018

Multipoint quantitative-trait linkage analysis in general pedigrees

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21579

Black Americans have an increased rate of angiotensin converting enzyme inhibitor-associated angioedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21579

The bradykinin-degrading aminopeptidase P is increased in women taking the oral contraceptive pill

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21579

Cloning, expression, and characterization of human cytosolic aminopeptidase P: a single manganese(II)-dependent enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21579

Bradykinin and the pathophysiology of angioedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21579

A variant in XPNPEP2 is associated with angioedema induced by angiotensin I-converting enzyme inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21579

Rat and mouse membrane aminopeptidase P: structure analysis and tissue distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21579

Genetic Contribution to Circulating Levels of Hemostatic Factors in Healthy Families With Effects of Known Genetic Polymorphisms on Heritability

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21579

Heritability of features of the insulin resistance syndrome in a community-based study of healthy families

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21579

Effect of bradykinin metabolism inhibitors on evoked hypotension in rats: rank efficacy of enzymes associated with bradykinin-mediated angioedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21579

Purification and characterization of pig kidney aminopeptidase P. A glycosyl-phosphatidylinositol-anchored ectoenzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21579

Ectoenzymes of the kidney microvillar membrane Aminopeptidase P is anchored by a glycosyl-phosphatidylinositol moiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21579

Effects of novel polymorphisms in the RAGE gene on transcriptional regulation and their association with diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21579

Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21579

Naturally occurring mutations in the human HNF4alpha gene impair the function of the transcription factor to a varying degree

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21579

International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21579

Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21579

Kinin-dependent hypersensitivity reactions in hemodialysis: metabolic and genetic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21579

Plasma bradykinin in angio-oedema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21579

Purification and characterization of guinea pig serum aminoacylproline hydrolase (aminopeptidase P)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21579

Liver-enriched transcription factors in liver function and development. Part I: the hepatocyte nuclear factor network and liver-specific gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21579

Cloning, chromosomal sublocalization of the human soluble aminopeptidase P gene (XPNPEP1) to 10q25.3 and conservation of the putative proton shuttle and metal ligand binding sites with XPNPEP2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21579

Assignment of the membrane-bound human aminopeptidase P gene (XPNPEP2) to chromosome Xq25.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21579

A comparison of bayesian methods for haplotype reconstruction from population genotype data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21579

A New Statistical Method for Haplotype Reconstruction from Population Data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21579

The angiotensin-converting enzyme gene family: genomics and pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21579

Cloning and tissue distribution of human membrane-bound aminopeptidase P

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21579

ACE inhibitor-induced angioedema. Incidence, prevention and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21579

PromoLign: a database for upstream region analysis and SNPs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21579

Aminopeptidase P in individuals with a history of angio-oedema on ACE inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21579

Des-Arg9-bradykinin metabolism in patients who presented hypersensitivity reactions during hemodialysis: role of serum ACE and aminopeptidase P

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21579

7 January 2021

Bradykinin and des-Arg(9)-bradykinin metabolic pathways and kinetics of activation of human plasma

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21579

7 January 2021

Inhibition of both aminopeptidase P and angiotensin-converting enzyme prevents bradykinin degradation in the rat coronary circulation

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21579

7 January 2021

Dipeptidyl peptidase IV activity in patients with ACE-inhibitor-associated angioedema

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21579

7 January 2021

Identifiers

DOI

10.1002/HUMU.21579

1 reference

8 May 2018

PubMed ID

21898657

1 reference

8 May 2018